Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis

By  

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 120-128

Bentham Science Publishers

Access to resources Recommend Favorite

Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 12, Iss. 2, 2006-01 ,pp. : 241-249

Bentham Science Publishers

Access to resources Recommend Favorite

Treating pain in multiple sclerosis

By Truini Andrea   Galeotti Francesca   Cruccu Giorgio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2355-2368

Informa Healthcare

Access to resources Recommend Favorite

Interferon-beta Inhibits Th17 Cell Differentiation in Patients with Multiple Sclerosis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 2, 2010-06 ,pp. : 161-167

Bentham Science Publishers

Access to resources Recommend Favorite

The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?

By Lee De-Hyung   Linker Ralf A  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 451-462

Informa Healthcare

Access to resources Recommend Favorite